The price for the same prescription drug in different hospitals nationwide could have more than a $10,000 difference, according to a new report. A report from 3 Axis Advisors used publicly available ...

Cost Plus Drugs partners with Bluesight and GraphiteRx to integrate pricing data, easing hospital access to affordable medications and managing shortages.

PatientRightsAdvocate.org, a national healthcare transparency advocacy organization focused on expanding access to upfront pricing information across the U.S. healthcare system, launched a free ...

Using nationally representative data, the authors found that for common physician-administered drugs, hospitals’ unilaterally set cash prices are frequently lower than their median—and sometimes even ...

A new report from Bluesight reveals how automation and analytics are helping hospital pharmacy teams cut spending, manage shortages, and streamline procurement. Despite drug costs projected to rise by ...

To understand just how problematic the current hospital drug shortage is, all you need to do is take a look at how it is impacting patients. Take for example the situation of one woman in New York.

Every few months a new analysis lands with the same headline: launch prices for new drugs outpace inflation. The latest reported that the median net launch price for 154 medicines rose 51 percent from ...

The Senate Health, Education, Labor, and Pensions Committee held a hearing last month examining the 340B drug discount program. A recurring line of questioning centered on whether 340B assistance is ...

A recent report from the Michigan Health Purchasers Coalition found wide variations in what Michigan hospitals charge for three different drugs. A separate survey from the Small Business Association ...

Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...